Antimicrobial Peptides Based on Bacterial S1 Protein Sequences as a Potential Alternative to Antibiotics
https://doi.org/10.33647/2074-5982-18-3-84-89
Abstract
An original approach to the development of antimicrobial peptides (AMPs) with a new mechanism of action based on directed coaggregation of a peptide with a target protein is proposed. The unique multifunctional bacterial ribosomal protein S1 was chosen as the target protein. The amyloidogenic and antibacterial effects of various peptides synthesized on the basis of S1 ribosomal protein sequences were studied. The results obtained can serve as a basis for the creation of new AMPs against various strains of pathogenic organisms.
About the Authors
O. V. GalzitskayaRussian Federation
Oxana V. Galzitskava - Dr. Sci. (Phys.-Math), Institute of Protein Research of the Russian Academy of Sciences; Institute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences.
142290, Moscow Region, Pushchino, Institutskaya Str., 4; 142290, Moscow Region, Pushchino, Institutskaya Str., 3.
A. V. Machulin
Russian Federation
Andrev V. Machulin - Cand. Sci. (Biol.), Skryabin Institute of Biochemistry and Physiology of Microorganisms of the Russian Academy of Sciences.
142290, Moscow Region, Pushchino, Nauki Ave., 5.
E. I. Deryusheva
Russian Federation
Evgeniva I. Deryusheva - Cand. Sci. (Phys.-Math), Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”.
142290, Moscow Region, Pushchino, Nauki Ave., 3.
A. V. Glyakina
Russian Federation
Anna V. Glyakina - Cand. Sci. (Phys.-Math), Institute of Protein Research of the Russian Academy of Sciences; Institute of Mathematical Problems of Biology of the Russian Academy of Sciences — Branch of “Federal Research Center Institute of Applied Mathematics named after M.V. Keldysh of the Russian Academy of Sciences”.
142290, Moscow Region, Pushchino, Institutskaya Str., 4; 142290, Moscow Region, Pushchino, Professora Vitkevicha Str., 1.
S. Yu. Grishin
Russian Federation
Sergei Yu. Grishin.
142290, Moscow Region, Pushchino, Institutskaya Str., 4.
S. R. Kurpe
Russian Federation
Stanislav R. Kurpe.
142290, Moscow Region, Pushchino, Institutskaya Str., 4.
A. V. Panfilov
Russian Federation
Alexander V. Panfilov.
142290, Moscow Region, Pushchino, Institutskaya Str., 4.
P. A. Domnin
Russian Federation
Pavel A. Domnin.
123098, Moscow, Gamalei Str., 18; 119991, Moscow, Leninskie Gory Str., 1.
S. V. Kravchenko
Russian Federation
Sergey V. Kravchenko.
625003, Tyumen, Lenina Str., 25.
S. A. Ermolaeva
Russian Federation
Svetlana A. Ermolaeva - Dr. Sci. (Biol.), National Research Center of Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health Care of Russia.
123098, Moscow, Gamalei Str., 18.
References
1. Kurpe S.R., Grishin S.Yu., Glyakina A.V., Slizen M.V., Panfilov A.V., Kochetov A.P., Surin A.K., Kobyakova M.I., Fadeev R.S., Galzitskaya O.V. Antibakterial'nye effekty peptidov, sintezirovannykh na osnove posledovatel'nosti ribosomnogo belka S1 [Antibacterial effects of peptides synthesized based on the sequence of the S1 ribosomal protein]. Biomedical Chemistry. 2021;67(3):231-243. (In Russian). DOI: 10.18097/PBMC20216703231.
2. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399(10325):629-655. DOI: 10.1016/S0140-6736(21)02724-0.
3. Brogden K. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Micro. 2005;3(3):238-250. DOI: 10.1038/nrmicro1098.
4. Galzitskaya O. Exploring amyloidogenicity of peptides from ribosomal S1 protein to develop novel AMPs. Front Mol. Biosci. 2021;8:705069. DOI: 10.3389/fmolb.2021.705069.
5. Ghanizadeh A., Najafizade M., Rashki S., Marzhosey-ni Z., Motallebi M. Genetic diversity, antimicrobial resistance pattern, and biofilm formation in Klebsiella pneumoniae isolated from patients with Coronavirus disease 2019 (COVID-19) and ventilator-associated pneumonia. Biomed. Res. Int. 2021;24:2347872. DOI: 10.1155/2021/2347872.
6. Grishin S., Deryusheva E.I., Machulin A.V., Selivanova O.M., Glyakina A.V., Gorbunova E.Y., Musta-eva L.G., Azev V.N., Rekstina V.V., Kalebina T.S., Surin A.K., Galzitskaya O.V. Amyloidogenic propensities of ribosomal S1 proteins: Bioinformatics screening and experimental checking. Int. J. Mol. Sci. 2020;21(15):5199. DOI: 10.3390/ijms21155199.
7. Grishin S., Dzhus U.F., Glukhov A.S., Selivanova O.M., Surin A.K., Galzitskaya O.V. Identification of amy-loidogenic regions in Pseudomonas aeruginosa ribosomal S1 protein. Int. J. Mol. Sci. 2021;22(14):7291. DOI: 10.3390/ijms22147291.
8. Kourtis A.P., Hatfield K., Baggs J., Mu Y., See I., Epson E., Nadle J., Kainer M.A., Dumyati G., Petit S., Ray S.M.; Emerging Infections Program MRSA author group, Ham D., Capers C., Ewing H., Coffin N., McDonald L.C., Jernigan J., Cardo D. Vital signs: Epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus Aureus bloodstream infections. MMWR Morb. Mortal. Wkly. Rep. 2019;68:214-219. DOI: 10.15585/mmwr.mm6809e1.
9. Kravchenko S., Domnin P.A., Grishin S.Y., Panfilov A.V., Azev V.N., Mustaeva L.G., Gorbunova E.Y., Kobyakova M.I., Surin A.K., Glyakina A.V., Fadeev R.S., Ermolaeva S.A., Galzitskaya O.V. Multiple antimicrobial effects of hybrid peptides synthesized based on the sequence of ribosomal S1 protein from Staphylococcus aureus. Int. J. Mol. Sci. 2022;23(1):524. DOI: 10.3390/ijms23010524.
10. Machulin A., Deryusheva E.I., Selivanova O.M., Galzitskaya O.V. The number of domains in the ribosomal protein S1 as a hallmark of the phylogenetic grouping of bacteria. PLoS One. 2019;14(8):e0221370. DOI: 10.1371/journal.pone.0221370.
11. Marazzato M., Scribano D., Sarshar M., Brunetti F., Fillo S., Fortunato A., Lista F., Palamara A.T., Zagaglia C., Ambrosi C. Genetic diversity of antimicrobial resistance and key virulence features in two extensively drug-resistant Acinetobacter baumannii isolates. Int. J. Environ. Res. Public Health. 2022;19(5):2870. DOI: 10.3390/ijerph19052870.
12. Mbhele Z., Shobo C.O., Amoako D.G., Zishiri O.T., Bester L.A. Occurrence, antibiotic resistance, virulence factors, and genetic diversity of Bacillus spp. from public hospital environments in South Africa. Microb. Drug Resist. 2021;27(12):1692-1704. DOI: 10.1089/mdr.2020.0543.
13. Sierra J., Vinas M. Future prospects for antimicrobial peptide development: Peptidomimetics and antimicrobial combinations. Expert Opin. Drug Discov. 2021;16(6): 601-604. DOI: 10.1080/17460441.2021.1892072.
Review
For citations:
Galzitskaya O.V., Machulin A.V., Deryusheva E.I., Glyakina A.V., Grishin S.Yu., Kurpe S.R., Panfilov A.V., Domnin P.A., Kravchenko S.V., Ermolaeva S.A. Antimicrobial Peptides Based on Bacterial S1 Protein Sequences as a Potential Alternative to Antibiotics. Journal Biomed. 2022;18(3):84-89. (In Russ.) https://doi.org/10.33647/2074-5982-18-3-84-89